| Authors: |
Grynblat J; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.; M3C-Necker, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris Cité, Cardiologie Congénitale et Pédiatrique, Paris, France., Hlavaty A; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France.; Grenoble Alpes University Hospital, Pharmacovigilance Unit and Clinical Pharmacology Department, Grenoble, France., Savale L; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Weatherald J; Department of Medicine, Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada., Le Bozec A; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France., Aguado B; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Chaumais MC; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Assistance publique - hôpitaux de Paris, Department of pharmacy, Bicêtre Hospital, Le Kremlin Bicêtre, France.; University of Paris-Saclay, School of pharmacy, Saclay, France., Humbert M; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France., Khouri C; Univ. Grenoble Alpes, HP2 Laboratory, INSERM U 1300, Grenoble, France., Montani D; INSERM UMR_S 999 'Pulmonary hypertension: pathophysiology and novel therapies', HPPIT, Marie Lannelongue Hospital and Bicêtre Hospital, Le Kremlin-Bicêtre, France.; Université Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France. |
